| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7389805 | Value in Health Regional Issues | 2017 | 6 Pages |
Abstract
This estimation indicates that dulaglutide dominates liraglutide. Its ICER is, however, greater than the accepted threshold for Colombia in base case compared with glargine. By increasing population weight or glargine consumption, dulaglutide becomes cost effective compared with glargine, which could identify a niche where dulaglutide is the best option.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Pieralessandro Lasalvia, Laura Baquero, Margarita MD, Camilo MD, Diego MD, MSc, MEd,